Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
HER3 V104 mutations regulate cell signaling, growth, and drug sensitivity in cancer
HER3 V104 mutations regulate cell signaling, growth, and drug sensitivity in cancer
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Rosalin Mishra
,
Mary Kate Kilroy
,
Wasim Feroz
,
Hima Patel
,
Joan T. Garrett
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
Molecular Carcinogenesis
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway
by: Hao Zhu, et al.
Published: (2024)
Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway through RAB27B
by: Qianjin Zhang, et al.
Published: (2024)
The anthraquinone derivative KA‐4s reduces energy metabolism and enhances the sensitivity of ovarian cancer cells to cisplatin
by: Yingdan Zhao, et al.
Published: (2024)
SIRT1 promotes doxorubicin‐induced breast cancer drug resistance and tumor angiogenesis via regulating GSH‐mediated redox homeostasis
by: Shashikanta Sahoo, et al.
Published: (2024)
Downregulation of ALDH5A1 suppresses cisplatin resistance in esophageal squamous cell carcinoma by regulating ferroptosis signaling pathways
by: Kewei Song, et al.
Published: (2024)
